Trial Profile
A comparative study of Sitagliptin- Glimepiride combinational therapy and Glimepiride monotherapy on the patients with diabetes mellitus after pancreatic biliary diseases including malignant disorders related subtotal pancreatectomy.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2019
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Sitagliptin (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 09 Jul 2019 Status changed from recruiting to discontinued.
- 05 Dec 2011 New trial record